Enzymes for Industrial Applications

Andreas Liese, TUHH

Liese_small


"Interdisciplinary R&D is the key to enable
industrial applications of biocatalysis"

 

Wed 4 Feb 2015, 11:55:

Biocatalysis - Key Technology in Sustainable Synthesis of Chemicals

  • Reaction engineering needs to complement molecular engineering
  • Consider thermodynamics besides kinetics when optimizing biotransformations
  • Evaluate hybride processes integrating down stream processing
  • Present and future perspectives in technical biocatalysis

 

CV:

Prof. Dr. Andreas Liese studied chemistry at the Friedrich-Wilhelms-University of Bonn, Germany and carried out his doctoral research at the Research Center Jülich, Germany, in close collaboration with DSM Research, Netherlands, receiving his PhD degree in 1998 from the Friedrich-Wilhelms-University of Bonn. From 1998 to 2003 Liese was assistant professor at the University of Bonn and at the same time head of the Enzyme Group within the Institute of Biotechnology II (Prof. Dr. C. Wandrey), Research Center Jülich. During a sabbatical in 2000 at Pfizer Global Research & Development, San Diego, USA, he there initiated a R&D group on biocatalysis. From 2003 to 2004 he worked as associate professor at the University of Münster, soon receiving a full professorship for Technical Biocatalysis 2004 at the Hamburg University of Technology (TUHH) as the director of the Institute of Technical Biocatalysis, which he continues to expand. In 2003 Liese received the Award of Up-and-Coming Teacher in Higher Education in the field of biotechnology (DECHEMA, Germany). He is elected member of the steering committee “Biotechnology” of the DECHEMA since 2005 and elected member of the steering committee of the German Society of Chemical Engineering and Biotechnology (DECHEMA) itself since 2014. From 2009 to 2013 he was elected member of the steering committee of the “German Catalysis Society, GeCatS”. His three books („Industrial Biotransformations“, „Biological Principles Applied to Technical Asymmetric Catalysis“ and “Biocatalysis for the Pharmaceutical Industry”) of which he is author deal with processes of white biotechnology.

 

 

 

 

 

Become a member